Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
The Scientist
Most Recent
The scientific community and the impact of the Myriad Genetics Supreme Court decision
Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
Top justices rule that police have the right to take DNA swabs from people who are arrested, even before they are convicted.
The justices unanimously upheld Monsanto’s patent rights on Roundup Ready seeds.
A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.
In an upcoming hearing, the US Supreme Court will decide on whether police can take DNA samples from suspects who have not been convicted.
The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.
Scientists fighting the federal funding of human embryonic stem cell research bring their case before the country’s highest court.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
